Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer

Phase 2

Terminated

Conditions: Esophageal Cancer
Adenocarcinoma of the Esophagus
Squamous Cell Carcinoma

Interventions: Drug: OncoGel (Paclitaxel gel)
Drug: cisplatin
Drug: 5-FU
Radiation: radiation therapy
Procedure: esophageal resection

First Posted Date: 2007-12-13

Last Posted Date: 2022-06-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 137

Registration Number: NCT00573131

Locations: 🇺🇸
University of California San Diego, San Diego, California, United States
🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

and more 17 locations

TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program

Phase 4

Completed

Conditions: Cardiovascular Disease
de Novo Coronary Lesions

First Posted Date: 2007-12-07

Last Posted Date: 2008-09-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 5016

Registration Number: NCT00569751

Locations: 🇺🇸
Scottsdale Healthcare, Scottsdale, Arizona, United States
🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States
🇺🇸
Desert Cardiology Consultants, Rancho Mirage, California, United States

and more 50 locations

TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program

Phase 4

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2007-12-07

Last Posted Date: 2008-09-25

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2585

Registration Number: NCT00569491

Locations: 🇺🇸
Advanced Cardiac Specialists, Gilbert, Arizona, United States
🇺🇸
Cardiology Associates of NEA, Jonesboro, Arkansas, United States
🇺🇸
University of California Davis Medical Center, Sacramento, California, United States

and more 47 locations

A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation

Phase 2

Completed

Conditions: Pediculus Humanus Capitis
Head Lice

Interventions: Drug: Placebo
Drug: BGC20-0582

First Posted Date: 2007-09-11

Last Posted Date: 2022-06-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 230

Registration Number: NCT00528021

Locations: 🇺🇸
Global Health Associates of Miami Inc, Florida City, Florida, United States

TheraSphere for the Treatment of Liver Metastases

Phase 2

Completed

Conditions: Colorectal Cancer
Neoplasm Metastasis
Carcinoma, Neuroendocrine

Interventions: Device: Yttrium 90 glass microspheres

First Posted Date: 2007-08-06

Last Posted Date: 2021-05-13

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 151

Registration Number: NCT00511862

Locations: 🇺🇸
Northwestern Memorial Hospital, Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
John Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 2 locations

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Phase 4

Withdrawn

Conditions: Secondary Liver Cancer
Liver Neoplasm
Metastatic Liver Cancer

Interventions: Device: Radiofrequency Ablation (RFA)
Drug: Chemotherapy

First Posted Date: 2007-08-02

Last Posted Date: 2017-03-03

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT00510627

Locations: 🇺🇸
New York University, New York, New York, United States
🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States

Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System

Phase 1

Completed

Conditions: Cardiovascular Diseases

Interventions: Device: Percutaneous Coronary Intervention (PCI) TAXUS Petal

First Posted Date: 2007-07-06

Last Posted Date: 2015-03-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 28

Registration Number: NCT00497367

Locations: 🇫🇷
Institut Hospitalier Jacques Cartier-ICPS, 6, Avenue du Noyer Lambert, Massy, France
🇩🇪
HELIOS Klinikum Siegburg, Ringstrasse 49, Siegburg, Germany
🇳🇿
Mercy Angiography Unit, 98 Mountain Road, First Floor, Auckland, Epsom, New Zealand

and more 1 locations

TAXUS PERSEUS Small Vessel

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: Percutaneous Coronary Intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation

First Posted Date: 2007-06-21

Last Posted Date: 2014-05-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 224

Registration Number: NCT00489541

Locations: 🇺🇸
Medical Center East, Birmingham, Alabama, United States
🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States
🇺🇸
Scripps Clinic, La Jolla, California, United States

and more 25 locations

Spinal Cord Stimulation for Painful Diabetic Neuropathy

Phase 4

Terminated

Conditions: Diabetic Neuropathy
Pain
Peripheral Neuropathy

Interventions: Device: Precision Spinal Cord Stimulation

First Posted Date: 2007-06-19

Last Posted Date: 2012-03-13

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1

Registration Number: NCT00487981

Locations: 🇺🇸
Deaconess Pain Management Center, Evansville, Indiana, United States

TAXUS PERSEUS Workhorse

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Express) placement
Device: Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation

First Posted Date: 2007-06-08

Last Posted Date: 2014-05-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1264

Registration Number: NCT00484315

Locations: 🇺🇸
Baptist Medical Center Princeton, Birmingham, Alabama, United States
🇺🇸
Medical Center East, Birmingham, Alabama, United States
🇺🇸
Bakersfield Memorial Hospital, Bakersfield, California, United States

and more 86 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy